ChromoGenics AB appoints Brian Nielsen as Country Manager Denmark.

ChromoGenics AB (publ) are increasing our sales efforts in Denmark by appointing Brian Nielsen as Country Manager.

Brian has 25 year of experience from the façade business. The last 10 years he has been building the façade business for Skandinaviska Glassystem AB in Denmark as responsible for sales, design production and assembly from small up to very large façade projects.

“I am very happy to be part of ChromoGenics as I can see huge potential for our products. The company is driven by innovation and responsibility for our environment”, says Brian Nielsen. “My goal is to deliver the most energy efficient glass in the world and its unique high climate comfort properties to Danish customers. We focus on the environmental footprint from start to finish during the complete lifecycle of the product. I think ConverLight is the best dynamic glass on the market measured on all parameters. ChromoGenics have unique products that are needed in the Danish market as the requirements are increasing all the time”

“I am very pleased that Brian Nielsen with his well suited background has decided to join our team at ChromoGenics. I think we will be extremely well positioned in the Danish market from now on” says Jerker Lundgren, CEO of ChromoGenics. 


Jerker Lundgren, CEO
Lars Ericsson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
Certified Adviser: G&W Fondkommission, e-mail:, tel.: +46 (0) 8 503 000 50

Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.

About ChromoGenics
ChromoGenics offers dynamic glass with controllable heat- and light transmission. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight® also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.

ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. 

Download as PDF


Subscribe to our news